The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...
Semaglutide, the active ingredient in medications like Ozempic and Wegovy, appears to help people reduce their alcohol ...
Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are ...
MedPage Today on MSN
Gabapentin Under Scrutiny: 2025 Data Challenged Safety Profile
In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated.
Madrigal’s Rezdiffra tops $1B run-rate in MASH, but losses and rising GLP-1/FGF21 competition may cap upside into 2026. See ...
The US has labelled Venezuela’s alleged Cartel de los Soles a Foreign Terrorist Organization amid Maduro’s capture. Experts say it’s a network of corruption, not a traditional cartel.
Consumer Analysis Examines Multi-Form Magnesium Formulation, Quality Testing Protocols, and Research Context as New Year ...
Zacks Investment Research on MSN
REGN soars 41% in six months: Is there more upside potential in 2026?
The going has been strong for Regeneron Pharmaceuticals REGN over the past six months. Shares of this biotech giant have ...
In the new Hulu documentary "I’m Chevy Chase And You’re Not," Chevy Chase's family members detail addiction and the family ...
As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own ...
The Sea Robbers, under coach Abdeslam Ouaddou, have been exceptional in the domestic competitions this season, where they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results